Coordinating center supporting small cell lung cancer research collaboration
Official title: Coordinating center for the NCI small cell lung cancer research consortium
Funded at Sloan-Kettering Inst Can Research · NIH-11321553 · Data updated 2026-11-12
A national coordinating center helps researchers, clinicians, and patient advocates share data, models, and resources to speed advances against small cell lung cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sloan-Kettering Inst Can Research NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | June 24, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,149,864 |
| NIH project number | 5U24CA213274-10 |
| Project ID | NIH-11321553 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with small cell lung cancer or those at risk/under surveillance who could benefit from future translational research and trials.
✕Less likely to help
Direct clinical benefit may not occur during the grant period, as this is primarily a coordinating and data-sharing effort.
What this research studies
This grant funds a coordinating center that connects many SCLC researchers and institutions, consolidating preclinical and clinical data, models, and analyses. It supports centralized databases, resource sharing, and collaborative activities like workshops and annual meetings to drive progress. The goal is to reduce knowledge gaps and accelerate discoveries that could lead to better treatments for people affected by SCLC.
Why it matters
Potential benefit: If successful, it could speed development of new treatments and improve access to shared data and resources for patients.
How similar studies have gone: Past work has shown that coordinated data sharing and collaborative platforms can accelerate cancer research progress.
Where this research is happening
-
Sloan-Kettering Inst Can Research
New York, United States Active
Researchers
- Principal investigator: Rudin, Charles M. — Sloan-Kettering Inst Can Research
- Study coordinator: Rudin, Charles M.
Related research
Other NIH-funded projects on the same topics.
-
ABL kinase signaling and DNA collisions in small cell lung cancer
A drug target study in small cell lung cancer explores how blocking ABL kinase affects conflicts between transcription and DNA replication, which could influence tumor growth and survival.
-
XRN1 as a potential therapy target in lung cancer
A scientist-led program will study a cellular gene called XRN1 to see if turning it off can help treat non-small cell lung cancer.
-
Intermittent fasting with PD-1 inhibitors for non-small cell lung cancer
This grant tests whether a fasting-mimicking diet can boost the effectiveness of PD-1 inhibitors for people with non-small cell lung cancer.
-
Targeting STRAP to curb NSCLC spread with nanoparticle therapy
Aimed at non-small cell lung cancer, this grant tests how blocking a protein called STRAP with nanoparticles could slow cancer spread and make chemotherapy work better.
-
Modeling tumor differences to guide new treatments for resistant small cell lung cancer
A study aims to understand why some small cell lung cancer tumors resist treatment and use those insights to develop new targeted therapies.
-
TP53-mutant NSCLC: how epigenetic viral mimicry could boost immune therapy
A research grant exploring how p53 mutations in non-small cell lung cancer affect responses to a viral mimicry-based epigenetic therapy, with the goal of improving immune therapy outcomes for patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.